http://www.thestreet.com/story/12400705/1/prana-bio-huntingtons-disease-drug-fails-key-efficacy-hurdles.html
interesting.
I've thought the same thing re meeting IL6 marker endpoint. IL6 could come down across the board, but if it doesn't beat Lupus symptoms, Invion would be in trouble.
prana example; endpoints don't mean much?
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(50.0%) |
Mkt cap ! $19.91M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $8.976K | 3.030M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 42 | 38902425 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 1994174 | 4 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| IVX (ASX) Chart |